Predicting prognosis in colorectal cancer patients with curative resection using albumin, lymphocyte count and RAS mutations.

We observed a significant trend in which the number of patients with a low-ALRI value increased as the stage progressed (RFS: p = 0.002) (Table 4 ).

also in 1,641 other papers

In stage I and II CRC, while there was a tendency towards a poorer prognosis in the high-ALRI group, the difference did not reach statistical significance (p = 0.129, 0.257; Fig. 3 A,B).

also in 14,934 other papers